Error: Could not add to watchlist. X

C&O Pharmaceutical Technology Holdings Ltd

+ Watchlist
COPT:SP
Acquired
COPT:SP was acquired by 4507:JP
SGD
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (HKD) (TTM)
0.201
Market Cap (SGD)
-
Shares Outstanding (m)
663.360
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Health Care Facilities & Svcs
Sub-Industry
Health Care Supply Chain

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
C&O Pharmaceutical Technology Holdings Ltd. manufactures generic drugs. The Company produces amoxicillin, cefradine and flucloxacilin, and the over-the-counter medicine Ambroxol. C&O markets its products in China.
ADDRESS
911-12 Silvercord Tower 2,
30 Canton Rd., Tsim Sha Tsui,
Kowloon
Hong Kong (SAR)
PHONE
852-2806-0109
  • Tatsuya Suto
    Chairman
  • Bin Gao
    Deputy Chairman/Co-Founder
  • Trevor Choi
    Chief Financial Officer
  • Katsuya Okuyama
    Executive Director
  • Masaki Tomiyama
    Executive Director
Show More